The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACHILLION PHARMACEUTICALS IN | COM | 00448Q201 | 2,096 | 497,807 | SH | SOLE | 497,807 | 0 | 0 | ||
| AETNA INC NEW | COM | 00817Y108 | 11,352 | 89,000 | SH | SOLE | 89,000 | 0 | 0 | ||
| AMERISOURCEBERGEN CORP | COM | 03073E105 | 11,151 | 126,000 | SH | SOLE | 126,000 | 0 | 0 | ||
| ANIKA THERAPEUTICS INC | COM | 035255108 | 7,888 | 181,573 | SH | SOLE | 181,573 | 0 | 0 | ||
| CHARLES RIV LABS INTL INC | COM | 159864107 | 7,701 | 85,612 | SH | SOLE | 85,612 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 7,947 | 117,000 | SH | SOLE | 117,000 | 0 | 0 | ||
| GNC HLDGS INC | COM CL A | 36191G107 | 3,113 | 422,955 | SH | SOLE | 422,955 | 0 | 0 | ||
| IMMUCELL CORP | COM PAR $0.10 | 452525306 | 931 | 168,323 | SH | SOLE | 168,323 | 0 | 0 | ||
| MCKESSON CORP | COM | 58155Q103 | 7,561 | 51,000 | SH | SOLE | 51,000 | 0 | 0 | ||
| OSIRIS THERAPEUTICS INC NEW | COM | 68827R108 | 5,473 | 1,140,222 | SH | SOLE | 1,140,222 | 0 | 0 | ||